Oct eleven (Reuters) - the ecu Union's drugs regulator referred to it became evaluating a marketing authorisation for an antibody cocktail developed via Roche and Regeneron for the treatment and prevention of COVID-19 in people above the age of 12.
the european drug treatments agency observed on Monday it is going to assess the hazards and benefits of the drug, known as Ronapreve, and that it could problem an opinion inside two months. The company has already started a rolling review of the remedy.
(Reporting with the aid of Yadarisa Shabong in Bengaluru)
0 Comments